Is Emerson Electric Stock Outperforming the Nasdaq?

When we think about the machinery and technology that keep factories running, Emerson Electric Co. (EMR) is one of those names working behind the scenes. The Saint Louis, Missouri-based technology and software company has been around since 1890 and today serves customers across the Americas, Europe, Asia, the Middle East, and Africa. Its business spans everything from automation and control systems to measurement tools, industrial software, valves, and safety solutions.

Through brands such as Fisher, Rosemount, DeltaV, and RIDGID, Emerson helps industries measure, monitor, automate, and manage their operations. Whether it is controlling a plant process or improving workplace safety, the company's products are deeply woven into modern industrial operations.

That scale is also reflected in Emerson's market value. With a market capitalization of approximately $85.6 billion, the company comfortably falls within the "large-cap" category, which generally includes companies valued at $10 billion or more. Its sizeable market cap highlights Emerson's established presence, broad industrial footprint, and strong position within the specialty industrial machinery industry.

That solid performance has kept EMR on investors' radar, although the stock has pulled back a bit from its recent peak. Shares are currently 8.1% below the 52-week high of $166.35 reached on Aug. 12. Still, the broader picture remains encouraging. Over the past three months, EMR has gained 7.6%, easily beating the Nasdaq Composite's ($NASX) 1.2% slip during the same period.

So far in 2026, the stock is up 15.1%, slightly ahead of the index's 14.1% gain. However, over the past 52 weeks, EMR's 14.8% advance has trailed the Nasdaq's stronger 22.1% return, showing that its recent momentum has been more convincing than its longer-term performance.

The stock may have had a few wobbles, but the technical picture still looks encouraging. EMR has stayed above both its 50-day and 200-day moving averages since July, suggesting that buyers continue to have the upper hand. For now, that positioning points to a healthy underlying trend and keeps the stock's longer-term momentum looking positive.